GET THE APP

An unusual presentation of an unusual disease: Myopericarditis | 53034
Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

An unusual presentation of an unusual disease: Myopericarditis


6th International Conference on Clinical & Experimental Cardiology

November 30-December 02, 2015 San Antonio, USA

Harjot Singh and Rafay Abbassi

West Suburban Medical Center, USA

Posters-Accepted Abstracts: J Clin Exp Cardiolog

Abstract :

Myopericarditis is an inflammation of both the pericardial sac and the myocardium. In clinical practice they usually co-exist. The clinical presentation is variable and depends on the area of myocardium involved. Symptoms range from mild to no chest pain to fulminant heart failure, syncope or sudden cardiac death. About 50% of the cases are idiopathic and the rest can be divided into infectious, neoplastic, autoimmune, metabolic, trauma, and drugs. The most likely etiology involves a viral infection ��?commonly Coxsackie B. 27 year old AAM with no past medical history came to the ED with abdominal pain. CT of the abdomen showed widespread pneumatosis, consistent with perforated viscus favoring a ruptured appendix. Patient was unstable and was emergently taken to the or during surgery, large amount of purulent material was found in the peritoneal cavity, after which patient was transferred to the ICU. At this time patient troponin level was undetectable. Echo showed EF of 70% with no Wall motion abnormality (WMA). Despite being on appropriate antibiotics for two days, WBC was elevated with worsening LFT��?s, and creatinine. On day 3, new ST elevation were noted on telemetry mainly in leads II, III, avF and V5 with a troponin level of 57. Patient was started on ASA, and a heparin drip, though the suspicion for atherosclerotic disease was low (young age and no risk factors). Patient maintained his EF on the repeat echo and still did not have any WMA. Repeat CT of the abdomen showed multiple areas of loculated fluid, one of which was along the liver margin, directly underneath the right ventricle. The Next day, the patient was taken back to the OR for an abdominal washout. Subsequently, patient had resolution of ST elevations, heparin was discontinued, and troponins had normalized within 2 days. Myopericarditis can be diagnosed when there is an elevation of cardiac biomarkers in the presence or absence of chest pain or if there is myocardial inflammation seen on the cardiac MR or acute heart failure with reduced EF. Other common findings are ventricular arrhythmias, new bundle branch blocks and IVCD. It��?s very unique to have myocardial damage through a localized infectious source such as an abscess as in this case and present with STEMI. It��?s important to acknowledge the etiology because management of myopericarditis induced STEMI is very different from when there is an occlusive coronary artery disease. This patient was managed medically with ASA, blockers and Lisinopril as tolerated without activating the CATH lab. Understanding the pathophysiology can help with decision making when caring for patients with an unusual presentation.

Top